Finally, our results also provide evidence that the combination of both DFMO and sulindac inhibit both components of SOCs, the inward and outward components driven by both Orai1 and TRPC1 channels leading to efficient inhibition of SOCs and CRC chemoprevention. The gene discussed is CISH; the disease is colorectal carcinoma.